A Phase 1, Double-Blind, Randomized Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Resveratrol (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sirtris
- 26 Jan 2010 Actual patient number (9) added as reported by ClinicalTrials.gov.
- 26 Jan 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 26 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.